Give me answer on Pre operation evaluation of lung resection for md exam answer 10 marks

Reading File

Finding Sources

Reading File

Loading Image

I now have comprehensive material from multiple authoritative textbooks. Let me compile the complete MD exam answer.

Pre-operative Evaluation of Lung Resection

(10-mark MD Exam Answer)

Introduction

Pre-operative evaluation before lung resection aims to identify whether a patient with "resectable" disease is also "operable" - i.e., can tolerate the proposed resection with acceptable risk. The evaluation follows a structured three-domain approach often called the "three-legged stool" of respiratory assessment:

Lung mechanical function (spirometry)
Pulmonary parenchymal function (gas exchange / DLCO)
Cardiopulmonary reserve (exercise testing)

Miller's Anesthesia, 10e (KEY POINTS)

I. History and Clinical Assessment

Detailed history of quality of life gives the best functional assessment of respiratory reserve
Establish smoking history - cessation >8 weeks pre-op reduces secretions and reactive airways
Symptoms of dyspnea, exercise intolerance, hemoptysis, weight loss
Comorbidities: COPD, IHD, hypertension, diabetes, renal disease
Current medications (especially anticoagulants, beta-blockers, inhalers)
Prior thoracic surgery, radiotherapy, chemotherapy

II. Cardiac Evaluation

Cardiac complications occur in 10-15% of thoracic patients. The Thoracic Revised Cardiac Risk Index (ThRCRI) is used, incorporating:

Risk Factor	Score
Pneumonectomy planned	+1.5
Prior ischemic heart disease	+1.5
Prior stroke or TIA	+1.5
Serum creatinine >2 mg/dL	+1

Patients with major cardiac risk factors require formal cardiology evaluation per ACC/AHA guidelines
ECG, echocardiogram where indicated
Coronary angiography/revascularization if significant CAD identified
Beta-blockers should be continued perioperatively if already prescribed
Mulholland and Greenfield's Surgery, 7e, p. 917-919

III. Respiratory Mechanical Function - Spirometry

All patients undergoing pulmonary resection must have baseline spirometry.

Key parameter: FEV1 (Forced Expiratory Volume in 1 second)

The predicted postoperative FEV1 (ppoFEV1) is calculated as:

ppoFEV1 = preoperative FEV1 × (1 - fraction of functional lung tissue removed)

For lobectomy: segment counting method - ppoFEV1 = preop FEV1 × (1 - y/z) where y = functional segments removed, z = total functional segments
For pneumonectomy: use V/Q scan - ppoFEV1 = preop FEV1 × (1 - fraction of total perfusion in resected lung)

Risk thresholds:

ppoFEV1 >60% predicted → Low risk
ppoFEV1 30-60% predicted → Moderate risk - proceed to exercise testing
ppoFEV1 <30% predicted → High risk - proceed to CPET; mortality risk >10%
Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 1039

IV. Gas Exchange - Diffusing Capacity (DLCO)

DLCO (Diffusion Lung Capacity for Carbon Monoxide) reflects total functioning alveolar-capillary surface area
ppoDLCO calculated the same way as ppoFEV1

Risk thresholds mirror FEV1:

ppoDLCO >60% → Low risk
ppoDLCO 30-60% → Moderate risk - exercise testing
ppoDLCO <30% → High risk - CPET mandatory
If both ppoFEV1 and ppoDLCO >60% - patient is at low risk and can proceed directly to surgery
Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 1039-1040

V. Cardiopulmonary Exercise Testing (CPET)

This is the gold standard for assessing cardiopulmonary interaction. It is indicated when ppoFEV1 or ppoDLCO is <60%.

Step-test / Stair Climb Test (SCT) - low-technology screening:

Able to climb >22 metres (≈3 flights) → Low risk → can proceed
Climb <22 metres → Proceed to formal CPET

Shuttle Walk Test (SWT):

400 metres → Low risk
<400 metres → Formal CPET

Formal CPET - VO2 max (maximal oxygen consumption):

VO2 max	Risk
>20 mL/kg/min (or >75% predicted)	Low risk - proceed
10-20 mL/kg/min (or 35-75%)	Moderate risk - discuss alternatives
<10 mL/kg/min (or <35%)	High risk - major resection not recommended

Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 1039-1040

VI. ACCP Algorithm - Risk Stratification

The following algorithm (ACCP 2013 guidelines) guides decision-making:

ACCP Algorithm for Thoracotomy and Major Anatomic Resection

Algorithm 14.3B - Physiologic Evaluation prior to Lung Resection (ACCP guidelines, Mulholland & Greenfield Surgery 7e)

Risk definitions:

Low risk: Expected mortality <1%; major anatomic resection safe
Moderate risk: Morbidity/mortality variable; risks/benefits discussed with patient
High risk: Mortality after standard resection may exceed 10%; counsel for alternative surgical or nonsurgical options
Mulholland and Greenfield's Surgery, 7e, p. 917-919

VII. V/Q Scintigraphy

Indicated particularly for pneumonectomy candidates with borderline function
Provides the relative contribution of each lobe/lung to overall pulmonary function
Allows calculation of split lung function to refine ppoFEV1 and ppoDLCO estimates
Essential when there is doubt about whether a single remaining lung will be adequate

VIII. Additional Investigations

Investigation	Purpose
Chest X-ray / CT Thorax	Staging, anatomy, pleural disease
ABG (Arterial Blood Gas)	Baseline PaO2/PaCO2, hypercapnia is a poor sign (PaCO2 >45 = high risk)
FBC	Anemia, polycythemia
LFT, RFT, Electrolytes	Organ function
Coagulation profile	Pre-thoracotomy baseline
Echocardiography	Ventricular function, pulmonary hypertension
Bronchoscopy	Central airway assessment, tumor involvement

IX. Specific Risk Factors

Age: Age alone is not a contraindication. Preoperative exercise capacity is the best predictor of outcome in elderly patients. Geriatric patients have high risk for post-thoracotomy arrhythmias (AF occurs in up to 30-50% after major resections, peaking on day 2).

Post-operative Atrial Fibrillation risk factors:

Male >55 years, resting HR >72 bpm, pneumonectomy (60% AF) > lobectomy (40%)
Prophylaxis: diltiazem (drug of choice), amiodarone, magnesium, statins

COPD: Bronchodilator therapy should be optimized pre-operatively. VATS approach significantly reduces respiratory complications in patients with underlying lung disease.

Miller's Anesthesia, 10e, p. 7086

X. Interventions to Reduce Risk

The following are evidence-based pre-operative interventions that reduce respiratory complications:

Smoking cessation (minimum 8 weeks before surgery)
Pre-operative physiotherapy and incentive spirometry
Inspiratory muscle training (Hulzebos et al. - reduces post-op complications)
Bronchodilator optimization in COPD
Treatment of respiratory infections before elective surgery
Nutritional optimization
Planning for thoracic epidural analgesia (shown to reduce respiratory complications post-operatively)
Consideration of VATS or minimally invasive approach in high-risk patients

Miller's Anesthesia, 10e (KEY POINTS); Mulholland & Greenfield's Surgery 7e

Summary Table

Parameter	Low Risk	Moderate Risk	High Risk
ppoFEV1	>60%	30-60%	<30%
ppoDLCO	>60%	30-60%	<30%
VO2 max	>20 mL/kg/min	10-20	<10 mL/kg/min
Stair climb	>22 m	-	<22 m
Shuttle walk	>400 m	-	<400 m
Expected mortality	<1%	Variable	>10%

Conclusion

Pre-operative evaluation before lung resection is a stepwise, multidisciplinary process. The three pillars - spirometry (FEV1), gas exchange (DLCO), and exercise capacity (CPET/stair climbing) - together stratify patients into low, moderate, and high risk. Predicted postoperative values (ppoFEV1 and ppoDLCO) are central to decision-making. Cardiac evaluation via the ThRCRI runs in parallel. High-risk patients should be counseled about lung-sparing alternatives (segmentectomy, VATS) or nonsurgical treatment. Preoperative optimization with smoking cessation, physiotherapy, and bronchodilator therapy can shift borderline patients to a safer operative category.

Key Sources:

Miller's Anesthesia, 10e - Ch. 49 (Thoracic Anesthesia)
Morgan & Mikhail's Clinical Anesthesiology, 7e - Ch. 25 (Thoracic Anesthesia)
Mulholland and Greenfield's Surgery, 7e - Algorithm 14.3 (ACCP 2013 Guidelines)
Fishman's Pulmonary Diseases and Disorders

This is a shared conversation. Sign in to Orris to start your own chat.